| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 4.97e-06 | 17 | 40 | 3 | GO:0046703 | |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 5.84e-05 | 6 | 40 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 1.09e-04 | 8 | 40 | 2 | GO:0032453 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 9.07e-04 | 95 | 40 | 3 | GO:0005546 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 1.43e-03 | 28 | 40 | 2 | GO:0141052 | |
| GeneOntologyMolecularFunction | adenylyltransferase activity | 1.75e-03 | 31 | 40 | 2 | GO:0070566 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.75e-03 | 31 | 40 | 2 | GO:0032452 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate binding | 1.82e-03 | 121 | 40 | 3 | GO:1902936 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.87e-03 | 32 | 40 | 2 | GO:0140457 | |
| GeneOntologyBiologicalProcess | susceptibility to natural killer cell mediated cytotoxicity | 5.63e-07 | 9 | 40 | 3 | GO:0042271 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 1.29e-06 | 42 | 40 | 4 | GO:0043032 | |
| GeneOntologyBiologicalProcess | positive regulation of type II interferon production | 1.61e-06 | 103 | 40 | 5 | GO:0032729 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 3.72e-06 | 16 | 40 | 3 | GO:0002486 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 4.03e-06 | 124 | 40 | 5 | GO:0030101 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 4.51e-06 | 17 | 40 | 3 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 4.51e-06 | 17 | 40 | 3 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 5.40e-06 | 18 | 40 | 3 | GO:0002428 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 5.84e-06 | 61 | 40 | 4 | GO:0032814 | |
| GeneOntologyBiologicalProcess | cellular response to exogenous dsRNA | 1.01e-05 | 22 | 40 | 3 | GO:0071360 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.16e-05 | 23 | 40 | 3 | GO:0019885 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon production | 1.20e-05 | 155 | 40 | 5 | GO:0032649 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.41e-05 | 76 | 40 | 4 | GO:0042269 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 1.51e-05 | 25 | 40 | 3 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 1.51e-05 | 25 | 40 | 3 | GO:0002475 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.72e-05 | 80 | 40 | 4 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 1.81e-05 | 81 | 40 | 4 | GO:0043030 | |
| GeneOntologyBiologicalProcess | type II interferon production | 1.82e-05 | 169 | 40 | 5 | GO:0032609 | |
| GeneOntologyBiologicalProcess | positive regulation of response to tumor cell | 2.14e-05 | 28 | 40 | 3 | GO:0002836 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response to tumor cell | 2.14e-05 | 28 | 40 | 3 | GO:0002839 | |
| GeneOntologyBiologicalProcess | cellular response to dsRNA | 2.14e-05 | 28 | 40 | 3 | GO:0071359 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 3.22e-05 | 32 | 40 | 3 | GO:0019883 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell activation | 4.24e-05 | 35 | 40 | 3 | GO:0032816 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 5.03e-05 | 105 | 40 | 4 | GO:0042267 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 5.82e-05 | 109 | 40 | 4 | GO:0002228 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated cytotoxicity | 6.35e-05 | 40 | 40 | 3 | GO:0045954 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 6.84e-05 | 41 | 40 | 3 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 7.36e-05 | 42 | 40 | 3 | GO:0001916 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated immunity | 8.47e-05 | 44 | 40 | 3 | GO:0002717 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 9.62e-05 | 124 | 40 | 4 | GO:0001910 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.17e-04 | 49 | 40 | 3 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.24e-04 | 50 | 40 | 3 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 1.48e-04 | 53 | 40 | 3 | GO:0001914 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 1.50e-04 | 139 | 40 | 4 | GO:0019882 | |
| GeneOntologyBiologicalProcess | macrophage activation | 1.54e-04 | 140 | 40 | 4 | GO:0042116 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 1.65e-04 | 55 | 40 | 3 | GO:0043330 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.74e-04 | 56 | 40 | 3 | GO:0002418 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 1.85e-04 | 147 | 40 | 4 | GO:0031341 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 2.11e-04 | 449 | 40 | 6 | GO:0002449 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.46e-04 | 462 | 40 | 6 | GO:0002460 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 2.48e-04 | 63 | 40 | 3 | GO:0043331 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 2.49e-04 | 294 | 40 | 5 | GO:0044706 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide biosynthetic process | 2.72e-04 | 65 | 40 | 3 | GO:0045429 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 2.75e-04 | 163 | 40 | 4 | GO:0002456 | |
| GeneOntologyBiologicalProcess | penetration of zona pellucida | 2.82e-04 | 13 | 40 | 2 | GO:0007341 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide metabolic process | 2.97e-04 | 67 | 40 | 3 | GO:1904407 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 3.38e-04 | 70 | 40 | 3 | GO:0001913 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 3.52e-04 | 71 | 40 | 3 | GO:0002347 | |
| GeneOntologyBiologicalProcess | maternal process involved in female pregnancy | 3.82e-04 | 73 | 40 | 3 | GO:0060135 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 3.98e-04 | 74 | 40 | 3 | GO:0002711 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 4.31e-04 | 76 | 40 | 3 | GO:0048002 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 4.63e-04 | 187 | 40 | 4 | GO:0001909 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 4.82e-04 | 79 | 40 | 3 | GO:0001912 | |
| GeneOntologyBiologicalProcess | negative regulation of dendritic spine development | 5.50e-04 | 18 | 40 | 2 | GO:0061000 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 6.61e-04 | 88 | 40 | 3 | GO:0031343 | |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | 7.91e-04 | 576 | 40 | 6 | GO:0002443 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokine production | 8.65e-04 | 586 | 40 | 6 | GO:0001819 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide biosynthetic process | 8.78e-04 | 97 | 40 | 3 | GO:0045428 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide metabolic process | 9.59e-04 | 100 | 40 | 3 | GO:0080164 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 1.04e-03 | 232 | 40 | 4 | GO:0002706 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 1.06e-03 | 405 | 40 | 5 | GO:0042742 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.09e-03 | 235 | 40 | 4 | GO:0002822 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 1.30e-03 | 111 | 40 | 3 | GO:0002709 | |
| GeneOntologyBiologicalProcess | nitric oxide biosynthetic process | 1.33e-03 | 112 | 40 | 3 | GO:0006809 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 1.41e-03 | 252 | 40 | 4 | GO:0002819 | |
| GeneOntologyBiologicalProcess | nitric oxide metabolic process | 1.66e-03 | 121 | 40 | 3 | GO:0046209 | |
| GeneOntologyBiologicalProcess | reactive nitrogen species metabolic process | 1.74e-03 | 123 | 40 | 3 | GO:2001057 | |
| GeneOntologyBiologicalProcess | response to lipopolysaccharide | 1.94e-03 | 464 | 40 | 5 | GO:0032496 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 2.47e-03 | 38 | 40 | 2 | GO:0001779 | |
| GeneOntologyBiologicalProcess | response to molecule of bacterial origin | 2.48e-03 | 491 | 40 | 5 | GO:0002237 | |
| GeneOntologyCellularComponent | side of membrane | 2.58e-05 | 875 | 39 | 9 | GO:0098552 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 4.31e-05 | 519 | 39 | 7 | GO:0009897 | |
| GeneOntologyCellularComponent | cell surface | 8.74e-04 | 1111 | 39 | 8 | GO:0009986 | |
| Domain | MHC_I | 1.27e-05 | 21 | 41 | 3 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 1.27e-05 | 21 | 41 | 3 | IPR001039 | |
| Domain | - | 1.92e-05 | 24 | 41 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 1.92e-05 | 24 | 41 | 3 | IPR011161 | |
| Domain | Lys_sp_deMease-like_dom | 2.81e-05 | 4 | 41 | 2 | IPR013637 | |
| Domain | PLU-1 | 2.81e-05 | 4 | 41 | 2 | PF08429 | |
| Domain | zf-C5HC2 | 4.68e-05 | 5 | 41 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 4.68e-05 | 5 | 41 | 2 | IPR004198 | |
| Domain | MHC_I/II-like_Ag-recog | 7.85e-05 | 38 | 41 | 3 | IPR011162 | |
| Domain | JmjN | 2.09e-04 | 10 | 41 | 2 | SM00545 | |
| Domain | JMJN | 2.09e-04 | 10 | 41 | 2 | PS51183 | |
| Domain | JmjN | 2.09e-04 | 10 | 41 | 2 | PF02375 | |
| Domain | JmjN | 2.09e-04 | 10 | 41 | 2 | IPR003349 | |
| Domain | NTP_transf_2 | 2.55e-04 | 11 | 41 | 2 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 2.55e-04 | 11 | 41 | 2 | IPR002934 | |
| Domain | IG_MHC | 3.08e-04 | 60 | 41 | 3 | PS00290 | |
| Domain | - | 4.85e-04 | 15 | 41 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 4.85e-04 | 15 | 41 | 2 | SM00501 | |
| Domain | ARID_dom | 4.85e-04 | 15 | 41 | 2 | IPR001606 | |
| Domain | ARID | 4.85e-04 | 15 | 41 | 2 | PS51011 | |
| Domain | ARID | 4.85e-04 | 15 | 41 | 2 | PF01388 | |
| Domain | JmjC | 1.26e-03 | 24 | 41 | 2 | PF02373 | |
| Domain | JMJC | 2.24e-03 | 32 | 41 | 2 | PS51184 | |
| Domain | JmjC_dom | 2.24e-03 | 32 | 41 | 2 | IPR003347 | |
| Domain | JmjC | 2.38e-03 | 33 | 41 | 2 | SM00558 | |
| Domain | CYSTEINE_SWITCH | 3.65e-03 | 41 | 41 | 2 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 4.01e-03 | 43 | 41 | 2 | IPR001818 | |
| Domain | fn3 | 5.36e-03 | 162 | 41 | 3 | PF00041 | |
| Domain | Ig/MHC_CS | 7.19e-03 | 58 | 41 | 2 | IPR003006 | |
| Domain | FN3 | 7.73e-03 | 185 | 41 | 3 | SM00060 | |
| Domain | ig | 8.32e-03 | 190 | 41 | 3 | PF00047 | |
| Domain | Immunoglobulin | 8.32e-03 | 190 | 41 | 3 | IPR013151 | |
| Domain | TSP_1 | 8.44e-03 | 63 | 41 | 2 | PF00090 | |
| Domain | TSP1 | 8.96e-03 | 65 | 41 | 2 | SM00209 | |
| Domain | TSP1_rpt | 8.96e-03 | 65 | 41 | 2 | IPR000884 | |
| Domain | TSP1 | 8.96e-03 | 65 | 41 | 2 | PS50092 | |
| Domain | Zinc_finger_PHD-type_CS | 8.96e-03 | 65 | 41 | 2 | IPR019786 | |
| Domain | FN3 | 9.43e-03 | 199 | 41 | 3 | PS50853 | |
| Domain | FN3_dom | 1.08e-02 | 209 | 41 | 3 | IPR003961 | |
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 25212604 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 12756263 | ||
| Pubmed | Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms. | 8.09e-09 | 4 | 45 | 3 | 20166740 | |
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 19081632 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 8882725 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 12421908 | ||
| Pubmed | MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation. | 2.02e-08 | 5 | 45 | 3 | 24572784 | |
| Pubmed | 2.02e-08 | 5 | 45 | 3 | 8982867 | ||
| Pubmed | Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D. | 4.04e-08 | 6 | 45 | 3 | 11825567 | |
| Pubmed | 4.04e-08 | 6 | 45 | 3 | 20219610 | ||
| Pubmed | 4.04e-08 | 6 | 45 | 3 | 10894171 | ||
| Pubmed | Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in northeastern Thais. | 4.04e-08 | 6 | 45 | 3 | 19688209 | |
| Pubmed | 4.04e-08 | 6 | 45 | 3 | 20976056 | ||
| Pubmed | Ligands for murine NKG2D display heterogeneous binding behavior. | 4.04e-08 | 6 | 45 | 3 | 11857333 | |
| Pubmed | The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. | 7.06e-08 | 7 | 45 | 3 | 16831899 | |
| Pubmed | 7.06e-08 | 7 | 45 | 3 | 20870941 | ||
| Pubmed | 7.06e-08 | 7 | 45 | 3 | 26151313 | ||
| Pubmed | NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis. | 7.06e-08 | 7 | 45 | 3 | 30787931 | |
| Pubmed | 7.06e-08 | 7 | 45 | 3 | 12370332 | ||
| Pubmed | 7.06e-08 | 7 | 45 | 3 | 25583577 | ||
| Pubmed | A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. | 1.13e-07 | 8 | 45 | 3 | 12645935 | |
| Pubmed | Gut microbiota regulates NKG2D ligand expression on intestinal epithelial cells. | 1.69e-07 | 9 | 45 | 3 | 23136011 | |
| Pubmed | Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. | 1.69e-07 | 9 | 45 | 3 | 14764662 | |
| Pubmed | A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. | 2.41e-07 | 10 | 45 | 3 | 11827464 | |
| Pubmed | Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles. | 3.32e-07 | 11 | 45 | 3 | 26656785 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 32081420 | ||
| Pubmed | Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven. | 1.64e-06 | 2 | 45 | 2 | 9060413 | |
| Pubmed | Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx. | 1.64e-06 | 2 | 45 | 2 | 10441747 | |
| Pubmed | Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus. | 1.64e-06 | 2 | 45 | 2 | 16416087 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 7524912 | ||
| Pubmed | Identification of a mouse male-specific transplantation antigen, H-Y. | 4.91e-06 | 3 | 45 | 2 | 7544442 | |
| Pubmed | The Histone Demethylase LSD1 Regulates B Cell Proliferation and Plasmablast Differentiation. | 4.91e-06 | 3 | 45 | 2 | 30232138 | |
| Pubmed | Novel JARID1C/SMCX mutations in patients with X-linked mental retardation. | 9.81e-06 | 4 | 45 | 2 | 16541399 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 32732223 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 7951230 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 19424970 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 17320160 | ||
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 19658097 | ||
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 31775046 | ||
| Pubmed | CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells. | 1.63e-05 | 5 | 45 | 2 | 27477692 | |
| Pubmed | 3.42e-05 | 7 | 45 | 2 | 28559451 | ||
| Pubmed | Involvement of EphA2 in the formation of the tail notochord via interaction with ephrinA1. | 3.42e-05 | 7 | 45 | 2 | 11287184 | |
| Pubmed | The composition and signaling of the IL-35 receptor are unconventional. | 5.86e-05 | 9 | 45 | 2 | 22306691 | |
| Pubmed | Basement membrane remodelling regulates mouse embryogenesis. | 8.94e-05 | 11 | 45 | 2 | 32523119 | |
| Pubmed | 1.27e-04 | 13 | 45 | 2 | 24619213 | ||
| Pubmed | 1.27e-04 | 13 | 45 | 2 | 14660691 | ||
| Pubmed | 1.28e-04 | 75 | 45 | 3 | 20637190 | ||
| Pubmed | The non-canonical Wnt-PCP pathway shapes the mouse caudal neural plate. | 1.70e-04 | 15 | 45 | 2 | 29636380 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 1.70e-04 | 15 | 45 | 2 | 14762062 | |
| Pubmed | 2.20e-04 | 17 | 45 | 2 | 19716815 | ||
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 2.47e-04 | 18 | 45 | 2 | 12023983 | |
| Pubmed | 3.06e-04 | 20 | 45 | 2 | 23637629 | ||
| Pubmed | 3.36e-04 | 104 | 45 | 3 | 10470851 | ||
| Pubmed | Failure of extra-embryonic progenitor maintenance in the absence of dosage compensation. | 4.07e-04 | 23 | 45 | 2 | 22573614 | |
| Pubmed | Spatiotemporal transcriptomic maps of whole mouse embryos at the onset of organogenesis. | 4.44e-04 | 24 | 45 | 2 | 37414952 | |
| Pubmed | Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. | 4.82e-04 | 25 | 45 | 2 | 19786569 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 5.07e-04 | 1105 | 45 | 7 | 35748872 | |
| Pubmed | 5.63e-04 | 27 | 45 | 2 | 36197846 | ||
| Pubmed | 6.06e-04 | 28 | 45 | 2 | 18839057 | ||
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 8.43e-04 | 33 | 45 | 2 | 26864203 | |
| Pubmed | Sexually dimorphic gene expression in the developing mouse gonad. | 9.48e-04 | 35 | 45 | 2 | 12617826 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q25 | 5.32e-04 | 164 | 44 | 3 | chr6q25 | |
| Cytoband | 17q21.33 | 7.19e-04 | 41 | 44 | 2 | 17q21.33 | |
| Cytoband | 17q25.3 | 4.27e-03 | 101 | 44 | 2 | 17q25.3 | |
| GeneFamily | AT-rich interaction domain containing | 2.40e-04 | 15 | 28 | 2 | 418 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 6.25e-04 | 24 | 28 | 2 | 485 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 1.92e-03 | 42 | 28 | 2 | 602 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 2.81e-03 | 51 | 28 | 2 | 870 | |
| GeneFamily | Immunoglobulin like domain containing | 3.22e-03 | 193 | 28 | 3 | 594 | |
| GeneFamily | PHD finger proteins | 8.52e-03 | 90 | 28 | 2 | 88 | |
| GeneFamily | Fibronectin type III domain containing | 2.53e-02 | 160 | 28 | 2 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.56e-02 | 161 | 28 | 2 | 593 | |
| Coexpression | GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP | 1.70e-05 | 196 | 43 | 5 | M3122 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.30e-07 | 157 | 45 | 5 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-05 | 170 | 45 | 4 | 054360a3b05f5e41221c98b122d241b1affad26a | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-05 | 170 | 45 | 4 | f0b0d2d0402de3ed7322284a599646db43475761 | |
| ToppCell | TCGA-Cervix|World / Sample_Type by Project: Shred V9 | 2.60e-05 | 170 | 45 | 4 | a6cbe253bc60f5d5cb361c7e85ed9928a3155ec8 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.46e-05 | 183 | 45 | 4 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.69e-05 | 186 | 45 | 4 | 055cc23c4db9aad2d6c62e62c8e58bfe5047c6b1 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 3.85e-05 | 188 | 45 | 4 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.93e-05 | 189 | 45 | 4 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.01e-05 | 190 | 45 | 4 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 190 | 45 | 4 | c1bfc1960a3df49c0f459454a7363804c32418ee | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Myelocyte-like|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.53e-05 | 196 | 45 | 4 | 4b88c96b737a747422674ad99c073b28e6febc7c | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.53e-05 | 196 | 45 | 4 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | 11.5-Airway-Endothelial-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 4.53e-05 | 196 | 45 | 4 | 509ddea8d6e1d0b832f69490ab8a736af4ca19a8 | |
| ToppCell | 11.5-Airway-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 4.53e-05 | 196 | 45 | 4 | e7d55933e23599122e20498548abf5b30fc25c8f | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.80e-05 | 199 | 45 | 4 | aca81a879ef9c196bd1885eff4c63ffe6c9682b7 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.89e-05 | 200 | 45 | 4 | d36236c7703b759309c8347f44900fc4bed377f0 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Tgfb2_(Tgfb2)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.42e-05 | 84 | 45 | 3 | 43e77117579290446a7e386c0be3459d652d9384 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Tgfb2_(Tgfb2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.42e-05 | 84 | 45 | 3 | 38a457a20701fe23c6326b7282cd0993cdd87082 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Tgfb2_(Tgfb2)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.42e-05 | 84 | 45 | 3 | 59d0415bb6b6b18a94d2c9c6289fa9cbcb2166e3 | |
| Drug | 2-[amino-[(2R,3R)-4-(dibenzylamino)-3-hydroxy-4-oxo-2-sulfanylbutanoyl]amino]acetic acid | 6.96e-07 | 37 | 43 | 4 | CID016040231 | |
| Drug | cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A | 1.76e-06 | 196 | 43 | 6 | 253_UP | |
| Drug | AC1NSE8A | 1.04e-05 | 3 | 43 | 2 | CID005359815 | |
| Drug | AZFd | 1.08e-05 | 23 | 43 | 3 | CID000196489 | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HG-U133A | 3.56e-05 | 199 | 43 | 5 | 484_DN | |
| Disease | level of UL16-binding protein 6 in blood serum | 1.98e-06 | 2 | 42 | 2 | OBA_2043185 | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 1.18e-05 | 4 | 42 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | magnesium measurement | 1.15e-04 | 66 | 42 | 3 | EFO_0004845 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 2.34e-04 | 16 | 42 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Neural Tube Defects | 8.39e-04 | 30 | 42 | 2 | C0027794 | |
| Disease | right ventricular ejection fraction measurement | 8.39e-04 | 30 | 42 | 2 | EFO_0021816 | |
| Disease | creatine measurement | 1.21e-03 | 36 | 42 | 2 | EFO_0010472 | |
| Disease | intellectual disability (implicated_via_orthology) | 5.14e-03 | 75 | 42 | 2 | DOID:1059 (implicated_via_orthology) | |
| Disease | albuminuria | 7.96e-03 | 94 | 42 | 2 | EFO_0004285 | |
| Disease | Depressive disorder | 8.05e-03 | 289 | 42 | 3 | C0011581 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CQAPQEPPAWGVSPK | 446 | Q5SNV9 | |
| GPDGKPVWNNPRPVC | 1601 | Q7Z408 | |
| PPHWGPQRGPRNAAA | 46 | Q495Z4 | |
| QVRAGWACPGQDPGP | 41 | Q9H9F9 | |
| WACPGQDPGPEPRLQ | 46 | Q9H9F9 | |
| ENPPCPAGLPGFRDW | 681 | Q8TE59 | |
| QWGLKNRPEPSCNGP | 431 | Q8NDF8 | |
| PPVQPCCLGPSKWGD | 56 | Q14296 | |
| DAPQPMGPNWLDCPA | 496 | Q9NPA2 | |
| CPQAWGPPGVQYGQP | 26 | Q14626 | |
| GPWPCPQDPLGAARC | 166 | Q14626 | |
| CWSPPGKRGQQPEKN | 51 | Q15053 | |
| GRRQKPPGVWPANPA | 176 | O00182 | |
| PPCSNWPQREKGIQG | 721 | Q99665 | |
| SGICKIRPPADWQPP | 41 | Q9BY66 | |
| CQVGLGPAQSWPLPP | 486 | P29376 | |
| NGSWPCRPPGDLINP | 841 | P26006 | |
| AARPVPGAPVPQGAW | 486 | H0YKK7 | |
| QKPPCRGGCWGQPGH | 6 | Q96S07 | |
| SPCFKDGTGNPIPPW | 666 | P29728 | |
| SPWGQPAPFCHPKQG | 7026 | Q5VST9 | |
| ALPECGKAPRPGAWP | 321 | Q5K4E3 | |
| PCPGPSWQGPKAGDS | 366 | O43603 | |
| SACKCPRKGPNPGPW | 191 | Q8N8I6 | |
| QLFPSGNKPGPCWPG | 556 | Q0VDD7 | |
| LCQPGPPSEKAWQPG | 96 | P15391 | |
| NLKEPPAGPAQPWGG | 776 | Q6MZW2 | |
| GCPPLWPNPAGNLYE | 351 | Q9NP62 | |
| WAGPTCQEPRPGPKE | 401 | O43820 | |
| PHGPPNKGAVPWGND | 846 | Q9ULH1 | |
| PGGRINCPWKVPPRA | 376 | P49641 | |
| RWECNRPAAPGGPLK | 111 | O43921 | |
| KQPQPLPMPCTGGCW | 1606 | Q5TBA9 | |
| PTPAPRAQVCGGQPW | 41 | P60008 | |
| CNPLIPRKGQGRPDW | 1646 | O95425 | |
| PTCAAQPPWPQGGQI | 1251 | O95255 | |
| PRGKGVPPPSWSQQC | 351 | Q8TF72 | |
| NTWGPFPVRPVNPGN | 1886 | Q8IWZ3 | |
| PPEPQAAGCRPQWGK | 406 | Q9UPR6 | |
| GTPFWSGPKQCPQPL | 701 | P41226 | |
| PKFRPGPRWCAVQGQ | 41 | Q6H3X3 | |
| NGEWVPGGKPEPQAP | 106 | O15178 | |
| PKFRPGPRWCAVQGQ | 41 | Q5VY80 | |
| PGPPDTPAQQLRCGW | 16 | Q9P283 | |
| GKEPCNWRRPGPKIP | 151 | Q6NUN9 | |
| PKFRPGPRWCAVQGQ | 41 | Q9BZM5 | |
| SGICKIRPPADWQPP | 41 | P41229 |